IRIDEX Corporation (IRIX)

Market Cap	11.94M -49.0%
Revenue (ttm)	51.57M +3.7%
Net Income	-3.55M
EPS	-0.21
Shares Out	17.56M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,668
Open	0.6870
Previous Close	0.6824
Day's Range	0.6800 - 0.7100
52-Week Range	0.6640 - 1.6480
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In fiscal year 2025, IRIDEX's revenue was $52.68 million, an increase of 8.23% compared to the previous year's $48.67 million. Losses were -$4.44 million, -50.20% less than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 10, 2026

Data Sources Report a data error